JPH11236357A - Halohydrin derivative and its production - Google Patents
Halohydrin derivative and its productionInfo
- Publication number
- JPH11236357A JPH11236357A JP10350270A JP35027098A JPH11236357A JP H11236357 A JPH11236357 A JP H11236357A JP 10350270 A JP10350270 A JP 10350270A JP 35027098 A JP35027098 A JP 35027098A JP H11236357 A JPH11236357 A JP H11236357A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- general formula
- dimethyl
- formula
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医薬中間体、例え
ばレチノールの中間体として有用な下記一般式(1)ま
たは(2)で示されるハロヒドリン誘導体およびその製
造法に関する。The present invention relates to a halohydrin derivative represented by the following general formula (1) or (2), which is useful as a pharmaceutical intermediate, for example, an intermediate of retinol, and a method for producing the same.
【0002】[0002]
【従来の技術】従来、一般式(1)または(2)で示さ
れるハロヒドリン誘導体は知られていない。2. Description of the Related Art Hitherto, halohydrin derivatives represented by the general formula (1) or (2) have not been known.
【0003】[0003]
【発明が解決しようとする課題】本発明は、一般式
(1)または(2)で示されるハロヒドリン誘導体およ
びその製造法を提供しようとするものである。SUMMARY OF THE INVENTION An object of the present invention is to provide a halohydrin derivative represented by the general formula (1) or (2) and a method for producing the same.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意検討した結果本発明に至った。す
なわち、本発明は、一般式(1) (式中、Rは水素原子またはヒドロキシル基の保護基を
示し、Xはハロゲン原子を示す。)で示されるハロヒド
リン誘導体、一般式(2) (式中、RおよびXは前記と同じ意味を表わす。)で示
されるハロヒドリン誘導体およびそれらの製造法を提供
するものである。Means for Solving the Problems The present inventors have made intensive studies to solve the above-mentioned problems, and as a result, have reached the present invention. That is, the present invention provides a compound represented by the general formula (1): (Wherein, R represents a hydrogen atom or a protecting group for a hydroxyl group, and X represents a halogen atom), a halohydrin derivative represented by the following general formula (2): (Wherein, R and X have the same meanings as described above) and a process for producing the same.
【0005】[0005]
【発明の実施の形態】以下本発明について、詳細に説明
する。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
【0006】本発明のハロヒドリン誘導体(1)または
(2)は、一般式(3) (式中、Rは前記と同じ意味を表わす。)で示されるト
リエン誘導体をハロヒドリン化反応に供することにより
得られる。The halohydrin derivative (1) or (2) of the present invention has the general formula (3) (Wherein, R represents the same meaning as described above), which is obtained by subjecting the triene derivative to a halohydrination reaction.
【0007】一般式(1)、(2)、および(3)で示
される化合物において、Rは水素原子もしくはヒドロキ
シル基の保護基を示す。ヒドロキシル基の保護基として
は例えば、ホルミル、アセチル、ピバロイル、ベンゾイ
ル、p−ニトロベンゾイルなどのアシル基、トリメチル
シリル、t−ブチルジメチルシリル、t−ブチルジフェ
ニルシリルなどのシリル基、テトラヒドロピラニル、メ
トキシメチル、メトキシエトキシメチル、1−エトキシ
エチルなどのアルコキシメチル基、ベンジル基、p−メ
トキシベンジル基、t−ブチル基、トリチル基、メチル
基、2,2,2−トリクロロエトキシカルボニル基、ア
リルオキシカルボニル基等が挙げられる。In the compounds represented by formulas (1), (2) and (3), R represents a hydrogen atom or a hydroxyl-protecting group. Examples of the hydroxyl-protecting group include, for example, acyl groups such as formyl, acetyl, pivaloyl, benzoyl and p-nitrobenzoyl, silyl groups such as trimethylsilyl, t-butyldimethylsilyl and t-butyldiphenylsilyl, tetrahydropyranyl, methoxymethyl , Methoxyethoxymethyl, alkoxymethyl groups such as 1-ethoxyethyl, benzyl group, p-methoxybenzyl group, t-butyl group, trityl group, methyl group, 2,2,2-trichloroethoxycarbonyl group, allyloxycarbonyl group And the like.
【0008】一般式(1)または(2)で示される化合
物において、Xのハロゲン原子としては、塩素原子、臭
素原子、またはヨウ素原子が挙げられる。In the compound represented by formula (1) or (2), examples of the halogen atom for X include a chlorine atom, a bromine atom and an iodine atom.
【0009】なお、原料化合物である一般式(3)で示
されるトリエン誘導体はゲラニオールより容易に製造で
き、EまたはZの幾何異性体のいずれであってもよく、
またその混合物であってもよい。The triene derivative represented by the general formula (3), which is a starting compound, can be easily produced from geraniol, and may be any of the geometric isomers of E or Z.
Further, a mixture thereof may be used.
【0010】本発明でハロヒドリン化反応に用いられる
過ハロゲン酸もしくはハロゲン酸またはそれらの金属塩
としては、具体的には過ヨウ素酸ナトリウム、過ヨウ素
酸カリウム、過ヨウ素酸、臭素酸、臭素酸ナトリウム、
臭素酸カリウム等が挙げられる。その使用量は一般式
(3)で示されるトリエン誘導体に対して、通常0.5
〜5モル倍程度、好ましくは0.8〜1.2モル倍程度
の範囲である。また、還元剤としては、亜硫酸水素塩、
亜硫酸塩、チオ硫酸塩もしくはそれらの水溶液が挙げら
れ、好ましくは、亜硫酸水素塩が挙げられる。具体的に
は、亜硫酸水素ナトリウム、亜硫酸ナトリウム、チオ硫
酸ナトリウム等が挙げられる。その使用量は一般式
(3)で示されるトリエン誘導体に対して、通常1〜1
0モル倍程度、好ましくは1.6〜2.4モル倍程度の
範囲である。The perhalic acid or halogen acid or a metal salt thereof used in the halohydrination reaction in the present invention includes, specifically, sodium periodate, potassium periodate, periodate, bromate, sodium bromate and the like. ,
Potassium bromate and the like can be mentioned. The amount thereof is usually 0.5 to the triene derivative represented by the general formula (3).
The range is about 5 to about 5 mole times, preferably about 0.8 to 1.2 mole times. As the reducing agent, bisulfite,
Sulfites, thiosulfates or aqueous solutions thereof are preferred, and bisulfites are preferred. Specific examples include sodium bisulfite, sodium sulfite, sodium thiosulfate, and the like. The amount used is generally 1 to 1 with respect to the triene derivative represented by the general formula (3).
The range is about 0 mole times, preferably about 1.6 to 2.4 mole times.
【0011】本発明でハロヒドリン化反応に用いられる
ハロゲン化剤としては、例えば塩素、次亜塩素酸、次亜
塩素酸t−ブチル、次亜塩素酸エチル、次亜塩素酸ナト
リウム、次亜塩素酸カリウム、次亜塩素酸カルシウム、
N−クロロ尿素、N−クロロスクシンイミド、クロラミ
ンT、クロラミンBなどの塩素化剤、臭素、次亜臭素
酸、次亜臭素酸t−ブチル、次亜臭素酸ナトリウム、次
亜臭素酸カリウム、N−ブロモ酢酸アミド、N−ブロモ
スクシンイミドなどの臭素化剤、ヨウ素、N−ヨードス
クシンイミドなどのヨウ素化剤が挙げられる。その使用
量は、特には限定されないが、一般式(3)で示される
トリエン誘導体に対して、約1〜2モル倍程度で充分目
的を達することができる。The halogenating agent used in the halohydrination reaction in the present invention includes, for example, chlorine, hypochlorous acid, t-butyl hypochlorite, ethyl hypochlorite, sodium hypochlorite, hypochlorous acid Potassium, calcium hypochlorite,
Chlorinating agents such as N-chlorourea, N-chlorosuccinimide, chloramine T, chloramine B, bromine, hypobromite, t-butyl hypobromite, sodium hypobromite, potassium hypobromite, N- Bromination agents such as bromoacetic acid amide and N-bromosuccinimide; and iodination agents such as iodine and N-iodosuccinimide. The amount of use is not particularly limited, but the purpose can be sufficiently achieved when the amount is about 1 to 2 times the molar amount of the triene derivative represented by the general formula (3).
【0012】本発明の反応には一般的には有機溶媒が用
いられ、水との混合溶媒として用いても好ましい。有機
溶媒としてはアセトニトリルなどのニトリル類、テトラ
ヒドロフラン、ジオキサン、ジメトキシエタン、ジエチ
ルエーテルなどのエーテル類、t−ブチルアルコール、
t−アミルアルコール、2−プロパノールなどのアルコ
ール類、塩化メチレン、クロロホルム、四塩化炭素など
のハロゲン化炭化水素類、アセトン、メチルイソプロピ
ルケトン、メチルイソブチルケトンなどのケトン類、ジ
メチルスルホキシド、アセトニトリル、N,N−ジメチ
ルホルムアミド、N,N−ジメチルアセトアミドなどの
非プロトン性極性溶媒が挙げられる。また使用量は特に
限定されない。In the reaction of the present invention, an organic solvent is generally used, and it is preferable to use a mixed solvent with water. As the organic solvent, nitriles such as acetonitrile, tetrahydrofuran, dioxane, dimethoxyethane, ethers such as diethyl ether, t-butyl alcohol,
alcohols such as t-amyl alcohol and 2-propanol; halogenated hydrocarbons such as methylene chloride, chloroform and carbon tetrachloride; ketones such as acetone, methyl isopropyl ketone and methyl isobutyl ketone; dimethyl sulfoxide; acetonitrile; Aprotic polar solvents such as N-dimethylformamide and N, N-dimethylacetamide. The amount used is not particularly limited.
【0013】本発明の反応温度は通常−78℃〜溶媒の
沸点の範囲、好ましくは0〜40℃の範囲である。ま
た、反応時間は反応温度によって異なるが、通常10分
〜48時間の範囲である。The reaction temperature of the present invention is generally in the range of -78 ° C to the boiling point of the solvent, preferably in the range of 0 to 40 ° C. The reaction time varies depending on the reaction temperature, but is usually in the range of 10 minutes to 48 hours.
【0014】反応終了後、得られた反応混合物に水を加
え、抽出した後、水等で洗浄し、有機層を濃縮すること
により一般式(1)および(2)で示されるハロヒドリ
ン誘導体を得ることができる。また、必要に応じて、シ
リカゲルクロマトグラフィーにより精製することができ
る。After completion of the reaction, water is added to the obtained reaction mixture, extracted, washed with water and the like, and the organic layer is concentrated to obtain a halohydrin derivative represented by the general formula (1) or (2). be able to. Further, if necessary, it can be purified by silica gel chromatography.
【0015】[0015]
【発明の効果】本発明により得られる一般式(1)、
(2)で示されるハロヒドリン誘導体は、医薬等中間
体、例えばレチノールの中間体として有用である。The general formula (1) obtained by the present invention,
The halohydrin derivative represented by (2) is useful as an intermediate such as a pharmaceutical, for example, an intermediate of retinol.
【0016】[0016]
【実施例】以下、実施例により本発明をさらに詳細に説
明するが、本発明はこれにより限定されるものではな
い。EXAMPLES The present invention will be described in more detail with reference to the following Examples, but it should not be construed that the present invention is limited thereto.
【0017】(実施例1)酢酸 3,7−ジメチル−
2,5,7−オクタトリエニル(5.16g、26.6
mmol)およびイオン交換水(0.48g、26.6
mmol)を含むジメチルスルホキシド(40mL)の
混合溶液を10℃に冷却し、これにN−ブロモスクシン
イミド(4.78g、26.6mmol)を加えた。反
応容器を冷媒から取り出し、室温で40分攪拌した。ガ
スクロマトグラフィーで原料の消失を確認したのち、イ
オン交換水(40mL)を加えた。これに酢酸エチル
(40mL)を加えて分液したのち、さらに水層を酢酸
エチル(35mLx2)で抽出した。合わせた有機層を
5%炭酸水素ナトリウム水(20mL)、飽和塩化ナト
リウム水(20mL)で順次洗浄し、無水硫酸ナトリウ
ムにて乾燥した。減圧濃縮して得られた黄色油状物
(9.12g)をシリカゲルカラムクロマトグラフィー
(展開溶媒ヘキサン:酢酸エチル=5:1、ついで3:
1)に供し、酢酸 8−ブロモ−7−ヒドロキシ−3,
7−ジメチル−2,5−オクタジエニル(1,2付加
体)(4.84g、収率62.5%)および酢酸 8−
ブロモ−5−ヒドロキシ−3,7−ジメチル−2,6−
オクタジエニル(1,4付加体)(1.28g、収率1
6.5%)を得た。 [1,2付加体] Rf:0.30(吸着剤 シリカゲル、展開溶媒 ヘキ
サン:酢酸エチル=3:1)1 H NMR(270MHz,CDCl3):δ 1.4
3(s,3H),1.70(s,3H),2.06
(s,3H),2.34(s,1H),2.78(d,
J=6.9Hz,2H),3.47(s,2H),4.
59(d,J=6.6Hz,2H),5.38(t,J
=6.6Hz,1H),5.57(d,J=15.5H
z,1H),5.74(dt,J=15.5Hz,6.
9Hz,1H) 13 C NMR(67.8MHz,CDCl3):δ 1
6.43,20.94,26.15,41.98,4
5.00,61.17,71.27,119.43,1
27.67,135.38,140.29,170.9
8 [1,4付加体] Rf:0.14(吸着剤 シリカゲル、展開溶媒 ヘキ
サン:酢酸エチル=3:1)1 H NMR(270MHz,CDCl3):δ 1.7
6(s,3H),1.82(s,3H),2.06
(s,3H),2.20(dd,J=13.5Hz,
5.6Hz,1H),2.30(dd,J=13.5H
z,7.9Hz,1H),2.67(br,1H),
3.95(s,2H),4.49(ddd,J=8.6
Hz,7.9Hz,5.6Hz,1H),4.59
(d,J=6.9Hz,2H),5.42(t,J=
6.9Hz,1H),5.58(d,J=8.6Hz,
1H)13 C NMR(67.8MHz,CDCl3):δ 1
4.94,16.62,20.76,40.07,4
6.81,60.90,66.09,121.92,1
32.65,133.72,137.48,170.8
9(Example 1) 3,7-dimethyl acetic acid
2,5,7-octatrienyl (5.16 g, 26.6
mmol) and ion-exchanged water (0.48 g, 26.6)
mmol) of dimethyl sulfoxide (40 mL)
The mixed solution was cooled to 10 ° C.
Imide (4.78 g, 26.6 mmol) was added. Anti
The reaction vessel was taken out of the refrigerant and stirred at room temperature for 40 minutes. Moth
After confirming the disappearance of the raw materials by chromatography,
On-exchange water (40 mL) was added. Ethyl acetate
(40 mL), and the mixture was separated.
Extracted with ethyl (35 mL × 2). Combined organic layers
5% aqueous sodium bicarbonate (20 mL), saturated sodium chloride
Wash sequentially with 20 mL of water, and dry with anhydrous sodium sulfate.
And dried. A yellow oil obtained by concentration under reduced pressure
(9.12 g) on silica gel column chromatography
(Developing solvent hexane: ethyl acetate = 5: 1, then 3:
1), and acetic acid 8-bromo-7-hydroxy-3,
7-dimethyl-2,5-octadienyl (1,2 addition
Isomer) (4.84 g, yield 62.5%) and acetic acid 8-
Bromo-5-hydroxy-3,7-dimethyl-2,6-
Octadienyl (1,4 adduct) (1.28 g, yield 1)
6.5%). [1,2 adduct] Rf: 0.30 (adsorbent silica gel, developing solvent
Sun: ethyl acetate = 3: 1)1 1 H NMR (270 MHz, CDClThree): Δ 1.4
3 (s, 3H), 1.70 (s, 3H), 2.06
(S, 3H), 2.34 (s, 1H), 2.78 (d,
J = 6.9 Hz, 2H), 3.47 (s, 2H), 4.
59 (d, J = 6.6 Hz, 2H), 5.38 (t, J
= 6.6 Hz, 1H), 5.57 (d, J = 15.5H)
z, 1H), 5.74 (dt, J = 15.5 Hz, 6.
9Hz, 1H) 13 C NMR (67.8 MHz, CDClThree): Δ 1
6.43, 20.94, 26.15, 41.98, 4
5.00, 61.17, 71.27, 119.43, 1
27.67, 135.38, 140.29, 170.9
8 [1,4 adduct] Rf: 0.14 (adsorbent silica gel, developing solvent
Sun: ethyl acetate = 3: 1)1 1 H NMR (270 MHz, CDClThree): Δ 1.7
6 (s, 3H), 1.82 (s, 3H), 2.06
(S, 3H), 2.20 (dd, J = 13.5 Hz,
5.6 Hz, 1 H), 2.30 (dd, J = 13.5 H)
z, 7.9 Hz, 1H), 2.67 (br, 1H),
3.95 (s, 2H), 4.49 (ddd, J = 8.6)
Hz, 7.9 Hz, 5.6 Hz, 1H), 4.59
(D, J = 6.9 Hz, 2H), 5.42 (t, J =
6.9 Hz, 1 H), 5.58 (d, J = 8.6 Hz,
1H)13 C NMR (67.8 MHz, CDClThree): Δ 1
4.94, 16.62, 20.76, 40.07, 4
6.81, 60.90, 66.09, 121.92, 1
32.65, 133.72, 137.48, 170.8
9
【0018】(実施例2)酢酸 3,7−ジメチル−
2,5,7−オクタトリエニル(500mg、2.57
mmol)を水10mlとアセトニトリル5mlに溶解
させ、過ヨウ素酸ソーダ(550mg、2.58mmo
l)を室温で添加して、その後1MのNaHSO3水溶
液5.4mlを室温で1時間かけて滴下した。室温で5
時間攪拌して、TLCにて原料が消失したのを確認し
て、水を注加してエーテルにて抽出した。有機層はNa
2SO3水溶液にて洗浄して無水硫酸マグネシウムにて乾
燥し、溶媒を留去することにより酢酸 8−ヨード−7
−ヒドロキシ−3,7−ジメチル−2,6−オクタジエ
ニル(870mg、2.57mmol)を100%の収
率で得た。Example 2 3,7-Dimethyl acetic acid
2,5,7-octatrienyl (500 mg, 2.57
mmol) was dissolved in 10 ml of water and 5 ml of acetonitrile, and sodium periodate (550 mg, 2.58 mmol) was added.
l) was added at room temperature, and then 5.4 ml of a 1 M aqueous NaHSO3 solution was added dropwise at room temperature over 1 hour. 5 at room temperature
After stirring for an hour, it was confirmed by TLC that the raw materials had disappeared, water was added, and the mixture was extracted with ether. The organic layer is Na
The extract was washed with an aqueous solution of 2 SO 3, dried over anhydrous magnesium sulfate, and evaporated to remove acetic acid 8-iodo-7.
-Hydroxy-3,7-dimethyl-2,6-octadienyl (870 mg, 2.57 mmol) was obtained in 100% yield.
【0019】(実施例3)酢酸 3,7−ジメチル−
2,5,7−オクタトリエニル(500mg、2.57
mmol)を水6mlとアセトニトリル10mlに溶解
させ、過ヨウ素酸2水和物(710mg、3.09mm
ol)を室温で添加して、その後1MのNaHSO3水
溶液5.4mlを0℃で1時間かけて滴下した。室温で
2時間攪拌して、TLCにて原料が消失したのを確認し
て、水を注加してエーテルにて抽出した。有機層はNa
2SO3水溶液にて洗浄して無水硫酸マグネシウムにて乾
燥し、溶媒を留去することにより酢酸 8−ヨード−7
−ヒドロキシ−3,7−ジメチル−2,5−オクタジエ
ニルと酢酸 8−ヨード−5−ヒドロキシ−3,7−ジ
メチル−2,5−オクタジエニルの約3:2の混合物
(800mg、2.36mmol)を92%の収率で得
た。Example 3 3,7-dimethyl acetic acid
2,5,7-octatrienyl (500 mg, 2.57
mmol) was dissolved in 6 ml of water and 10 ml of acetonitrile, and periodic acid dihydrate (710 mg, 3.09 mm
ol) at room temperature, followed by the dropwise addition of 5.4 ml of a 1 M aqueous NaHSO 3 solution at 0 ° C. over 1 hour. After stirring at room temperature for 2 hours, it was confirmed by TLC that the raw materials had disappeared, and water was added, followed by extraction with ether. The organic layer is Na
The extract was washed with an aqueous solution of 2 SO 3, dried over anhydrous magnesium sulfate, and evaporated to remove acetic acid 8-iodo-7.
A mixture of about 3: 2 of -hydroxy-3,7-dimethyl-2,5-octadienyl and 8-iodo-5-hydroxy-3,7-dimethyl-2,5-octadienyl acetate (800 mg, 2.36 mmol) was prepared. Obtained in 92% yield.
【0020】(実施例4)酢酸 3,7−ジメチル−
2,5,7−オクタトリエニル(1.0g、5.15m
mol)を水20mlとアセトニトリル10mlに溶解
させ、臭素酸ソーダ(0.93g、6.18mmol)
を室温で添加して、その後1MのNaHSO3水溶液1
2.4mlを室温で1時間かけて滴下した。室温で5時
間攪拌して、TLCにて原料が消失したのを確認して、
水を注加してエーテルにて抽出した。有機層はNa2S
O3水溶液にて洗浄して無水硫酸マグネシウムにて乾燥
し、溶媒を留去することにより酢酸 8−ブロモ−7−
ヒドロキシ−3,7−ジメチル−2,5−オクタジエニ
ルと酢酸 8−ブロモ−5−ヒドロキシ−3,7−ジメ
チル−2,6−オクタジエニルの約7:3の混合物
(1.4g、4.89mmol)を95%の収率で得
た。これらはカラムクロマトグラフィーによって分離で
きた。Example 4 3,7-Dimethyl acetic acid
2,5,7-octatrienyl (1.0 g, 5.15 m
mol) was dissolved in 20 ml of water and 10 ml of acetonitrile, and sodium bromate (0.93 g, 6.18 mmol) was dissolved.
At room temperature followed by 1M aqueous NaHSO3 1
2.4 ml was added dropwise over 1 hour at room temperature. After stirring at room temperature for 5 hours, TLC confirmed that the raw materials had disappeared.
Water was poured in and extracted with ether. The organic layer is Na2S
The mixture was washed with an aqueous solution of O3, dried over anhydrous magnesium sulfate, and the solvent was distilled off to give 8-bromo-7-acetic acid.
About 7: 3 mixture of hydroxy-3,7-dimethyl-2,5-octadienyl and 8-bromo-5-hydroxy-3,7-dimethyl-2,6-octadienyl acetate (1.4 g, 4.89 mmol) Was obtained in a yield of 95%. These could be separated by column chromatography.
【0021】(実施例5)酢酸 3,7−ジメチル−
2,5,7−オクタトリエニル(387mg、1.99
mmol)をアセトニトリル5mlに溶解させ、臭素
(400mg、2.50mmol)を水5mlとアセト
ニトリル1mlに溶解させた溶液を室温で滴下した。室
温で8時間攪拌して、TLCにて原料が消失したのを確
認して、水を注加してエーテルにて抽出した。有機層は
食塩水にて洗浄して無水硫酸マグネシウムにて乾燥し、
溶媒を留去することにより酢酸 8−ブロモ−7−ヒド
ロキシ−3,7−ジメチル−2,5−オクタジエニルと
酢酸 8−ブロモ−5−ヒドロキシ−3,7−ジメチル
−2,6−オクタジエニルの約7:3の混合物(569
mg、1.95mmol)を98%の収率で得た。これ
らはカラムクロマトグラフィーによって分離できた。Example 5 3,7-Dimethyl acetic acid
2,5,7-octatrienyl (387 mg, 1.99
mmol) in 5 ml of acetonitrile, and a solution of bromine (400 mg, 2.50 mmol) in 5 ml of water and 1 ml of acetonitrile was added dropwise at room temperature. After stirring at room temperature for 8 hours, the disappearance of the raw materials was confirmed by TLC, and water was added, followed by extraction with ether. The organic layer was washed with saline and dried over anhydrous magnesium sulfate,
By distilling off the solvent, about 8-bromo-7-hydroxy-3,7-dimethyl-2,5-octadienyl acetate and about 8-bromo-5-hydroxy-3,7-dimethyl-2,6-octadienyl acetate were obtained. 7: 3 mixture (569
mg, 1.95 mmol) in 98% yield. These could be separated by column chromatography.
【0022】(参考例1)酢酸ゲラニル(40g、2
0.4mmol)をヘキサン(100mL)に溶解し、
トリクロロイソシアヌル酸(17.1g、70.0mm
ol)を徐々に仕込み、−10℃〜0℃で6時間保温す
る。反応終了後、過剰のトリクロロイソシアヌル酸およ
び副生するイソシアヌル酸をろ過により系外に除去し
た。ろ液を5%炭酸水素ナトリウム、イオン交換水で順
次洗浄し、無水硫酸ナトリウムで乾燥したのち、溶媒を
留去することにより粗生成物を得た。これをシリカゲル
カラムクロマトグラフィーに供し、目的の酢酸 6−ク
ロロ−3,7−ジメチル−2,7−オクタジエニルを淡
黄色油状物として、収率85.5%で得た。Reference Example 1 Geranyl acetate (40 g, 2
0.4 mmol) in hexane (100 mL)
Trichloroisocyanuric acid (17.1 g, 70.0 mm
ol), and the mixture is kept warm at -10 ° C to 0 ° C for 6 hours. After the completion of the reaction, excess trichloroisocyanuric acid and by-produced isocyanuric acid were removed from the system by filtration. The filtrate was washed sequentially with 5% sodium hydrogen carbonate and ion-exchanged water, dried over anhydrous sodium sulfate, and then the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography to obtain the desired 6-chloro-3,7-dimethyl-2,7-octadienyl acetate as a pale yellow oil in a yield of 85.5%.
【0023】(参考例2)乾燥した4口フラスコに窒素
下、微粉末の水酸化ナトリウム(6.8g、0.17m
ol)、トリフェニルホスフィン(2.2g、8.5m
mol)、塩化テトラn−ブチルアンモニウム(1.4
g、5.1mmol)、塩化アリルパラジウムダイマー
(0.62g、1.7mmol)、テトラヒドロフラン
(100mL)を加える。そこへ、攪拌下、酢酸 6−
クロロ−3,7−ジメチル−2,7−オクタジエニル
(40g、0.17mmol)のテトラヒドロフラン溶
液(150mL)を室温で1時間かけて滴下する。室温
で3日間攪拌後、TLCにて原料の消失を確認して、反
応を終了する。反応混合物を水にあけ、エーテルで抽出
する。有機層を飽和塩化ナトリウム水溶液で洗浄し、無
水硫酸ナトリウムで乾燥し、溶媒を留去して粗生成物を
得た。これをシリカゲルカラムクロマトグラフィーに供
し、酢酸 3,7−ジメチル−2,5,7−オクタトリ
エニルを淡黄色油状物として収率65%で得た。REFERENCE EXAMPLE 2 Fine powdered sodium hydroxide (6.8 g, 0.17 m
ol), triphenylphosphine (2.2 g, 8.5 m)
mol), tetra-n-butylammonium chloride (1.4)
g, 5.1 mmol), allyl palladium chloride dimer (0.62 g, 1.7 mmol) and tetrahydrofuran (100 mL). There, with stirring, acetic acid 6-
A solution of chloro-3,7-dimethyl-2,7-octadienyl (40 g, 0.17 mmol) in tetrahydrofuran (150 mL) is added dropwise at room temperature over 1 hour. After stirring at room temperature for 3 days, the disappearance of the starting materials was confirmed by TLC, and the reaction was terminated. The reaction mixture is poured into water and extracted with ether. The organic layer was washed with a saturated aqueous solution of sodium chloride, dried over anhydrous sodium sulfate, and the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography to obtain 3,7-dimethyl-2,5,7-octatrienyl acetate as a pale yellow oily substance at a yield of 65%.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 世古 信三 大阪府高槻市塚原2丁目10番1号 住友化 学工業株式会社内 ──────────────────────────────────────────────────の Continuing on the front page (72) Inventor Shinzo Seko 2-10-1, Tsukahara, Takatsuki-shi, Osaka Sumitomo Chemical Industries, Ltd.
Claims (6)
示し、Xはハロゲン原子を示す。)で示されるハロヒド
リン誘導体または一般式(2) (式中、RおよびXは前記と同じ意味を表わす。)で示
されるハロヒドリン誘導体。1. The general formula (1) (Wherein, R represents a hydrogen atom or a protecting group for a hydroxyl group, and X represents a halogen atom), or a halohydrin derivative represented by the following general formula (2): (Wherein, R and X have the same meanings as described above).
リエン誘導体をハロヒドリン化反応させることを特徴と
する一般式(1)で示されるハロヒドリン誘導体および
一般式(2)で示されるハロヒドリン誘導体の製造法。2. The general formula (3) Wherein R represents the same meaning as described above, wherein a halohydrin derivative represented by the general formula (1) and a halohydrin derivative represented by the general formula (2) are obtained by subjecting a triene derivative represented by the following formula to a halohydrination reaction. Manufacturing method.
はハロゲン酸またはそれらの金属塩ならびに還元剤を用
いる請求項2に記載の製造法。3. The process according to claim 2, wherein a perhalic acid or a halogen acid or a metal salt thereof and a reducing agent are used in the halohydrination reaction.
を用いる請求項2に記載の製造法。4. The method according to claim 2, wherein a halogenating agent and water are used in the halohydrination reaction.
酸塩またはそれらの水溶液である請求項3に記載の製造
法。5. The method according to claim 3, wherein the reducing agent is a bisulfite, a sulfite, a thiosulfate or an aqueous solution thereof.
記載の製造法。6. The method according to claim 2, wherein the reaction temperature is 0 ° C. to 40 ° C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35027098A JP3747665B2 (en) | 1997-12-11 | 1998-12-09 | Halohydrin derivative and process for producing the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34127197 | 1997-12-11 | ||
JP9-341271 | 1997-12-11 | ||
JP35027098A JP3747665B2 (en) | 1997-12-11 | 1998-12-09 | Halohydrin derivative and process for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11236357A true JPH11236357A (en) | 1999-08-31 |
JP3747665B2 JP3747665B2 (en) | 2006-02-22 |
Family
ID=26576931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35027098A Expired - Fee Related JP3747665B2 (en) | 1997-12-11 | 1998-12-09 | Halohydrin derivative and process for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3747665B2 (en) |
-
1998
- 1998-12-09 JP JP35027098A patent/JP3747665B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3747665B2 (en) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2505669B2 (en) | Novel compound used for production of cholecalciferol derivative and process for producing the same | |
JPH11236357A (en) | Halohydrin derivative and its production | |
JPH0463056B2 (en) | ||
US7906495B2 (en) | Monohalogenovinyl vitamin D derivative compounds | |
EP0541446B1 (en) | Procedure for preparing 1R, cis 2,2-dimethyl-3-formyl cyclopropane-1-carboxylic acid lactone, and halogenated intermediates | |
JP2000086645A (en) | Epoxy derivative and its production | |
EP1375467B1 (en) | 2-Bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof | |
JPH035439A (en) | Production of optically active acylbiphenyl derivative | |
JPS6140669B2 (en) | ||
WO2000024713A1 (en) | Process for the preparation of retinol and intermediates therefor | |
JPS6126555B2 (en) | ||
JPS60158147A (en) | Preparation of 3-amino-4-fluoro-(6-halogeno)phenyl alkyl ether | |
JPS6019312B2 (en) | Method for producing oxazolinoazetidinylpentenoic acid derivatives | |
JPH0413694A (en) | Production of steroid derivative | |
JPH06100526A (en) | Phenoxyalkylcarboxylid acid derivative | |
JPS62230743A (en) | Production of 1-alkoxy-2-methylnaphthalene | |
JP3777818B2 (en) | Halogen compounds, triene derivatives and methods for producing them | |
FI66342B (en) | FOERENING ANVAENDBAR SAOSOM MELLANPRODUKT VID FRAMSTAELLNING AV THERAPEUTISKT VAERDEFULL 2- (6-METOXI-2-NAFTYL) PROPIONSYRA OCH DESS DERIVAT | |
JP2000063306A (en) | Trifluoropropanetetrol, its intermediate and their production | |
JP2003206270A (en) | Method of production for 2-methyl-5-phenylbenzonitrile | |
JPH09110742A (en) | 2-phenyl-1,2,3-tribromopropanes, 3-bromo-2-phenyl-1-propenes and their production | |
JP2005522475A (en) | Method for producing 2,4,5-trimethylphenylacetic acid | |
JPS59500864A (en) | 26,26.26,27.27,27-hexafluoro-1α,25-dihydroxycholesterol compound and method for producing the same | |
JPS6228156B2 (en) | ||
JPH021823B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051108 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051101 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051121 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081209 Year of fee payment: 3 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D05 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081209 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091209 Year of fee payment: 4 |
|
LAPS | Cancellation because of no payment of annual fees |